A COMPREHENSIVE SYSTEMATIC REVIEW OF THE ASSOCIATION BETWEEN VISCERAL OBESITY AND INCREASED CARDIOMETABOLIC DISEASE RISK: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES
The Indonesian Journal of General Medicine · 28.07.2026 · 43 (1) · 880-976
DOI: 10.70070/r23xkg06 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Indonesian Journal of General Medicine, online erschienen am 28.07.2026. Verfasst von Jeffy Marta. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Visceral adipose tissue (VAT) is a metabolically active, pro-inflammatory fat depot distinct from subcutaneous fat. Body mass index (BMI) and waist circumference (WC) cannot discriminate VAT from subcutaneous fat, misclassifying patients with normal-weight central adiposity. This review synthesised primary evidence linking visceral obesity to cardiometabolic disease across sixteen outcome domains.
Methods
The study strictly adhered to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines. Eligible designs comprised randomized controlled trials, cohort, case-control and observational studies quantifying VAT by imaging (CT, MRI, DXA) or validated surrogates (METS-VF, VAI, CVAI). Systematic reviews were excluded from primary tabulation. Two reviewers independently screened, extracted data and appraised risk of bias using Newcastle-Ottawa Scale and RoB 2; certainty was graded with GRADE. Synthesis was narrative and tabular.
Results
Fifty-two primary studies (36 observational, 16 RCTs) encompassing >400,000 participants were included. Incident CVD adjusted HRs ranged from 1.62 to 2.78. VAT predicted coronary heart disease independently of WC (HR 1.15 per SD), recurrent MACE (aHR 2.71), cardiovascular mortality (aHR 1.23 per SD; C-statistic 0.73), and all-cause mortality (HR 4.90 highest quartile). T2DM associations were markedly sex-divergent: adjusted ORs 2.62 in men and 32.49 in women. VAT predicted hypertension (OR 5.07) and metabolic syndrome (OR per SD 4.7 women, 4.2 men), persisting after BMI, WC and SAT adjustment. In normal-weight individuals, highest VAT quartile conferred 9-fold increased metabolic syndrome risk (OR 9.3). Randomized evidence demonstrated VAT modifiability: liraglutide 3.0 mg reduced VAT by 12.49% versus 1.63% with placebo (p
Zitieren
APA
Marta, J. (2026). A COMPREHENSIVE SYSTEMATIC REVIEW OF THE ASSOCIATION BETWEEN VISCERAL OBESITY AND INCREASED CARDIOMETABOLIC DISEASE RISK: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES. The Indonesian Journal of General Medicine, 43(1), 880-976. https://doi.org/10.70070/r23xkg06
Vancouver
Marta J. A COMPREHENSIVE SYSTEMATIC REVIEW OF THE ASSOCIATION BETWEEN VISCERAL OBESITY AND INCREASED CARDIOMETABOLIC DISEASE RISK: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES. The Indonesian Journal of General Medicine. 2026;43(1):880-976. doi:10.70070/r23xkg06
BibTeX
@article{Marta2026,
author = {Marta, Jeffy},
title = {A COMPREHENSIVE SYSTEMATIC REVIEW OF THE ASSOCIATION BETWEEN VISCERAL OBESITY AND INCREASED CARDIOMETABOLIC DISEASE RISK: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS AND PRIMARY STUDIES},
journal = {The Indonesian Journal of General Medicine},
year = {2026},
volume = {43},
number = {1},
pages = {880--976},
doi = {10.70070/r23xkg06}
}
EUVIMED